Preoperative Carbohydrate Loading in Bariatric Surgery

July 21, 2020 updated by: Medical University of Gdansk

Preoperative Carbohydrate Loading in Bariatric Surgery - Randomized Clinical Trail

The aim of this study is to perform a randomized non-blinded clinical trial to assess influence of preoperative carbohydrates loading in patients undergoing bariatric surgery measured by changes in the course of the postoperative period, changes in body composition and changes in insulin resistance

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

400

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pomerania
      • Gdańsk, Pomerania, Poland, 80-214
        • Recruiting
        • Department of General, Endocrine and Transplant Surgery Medical University of Gdańsk
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Obtaining written and informed patient consent.
  • No medical contraindications to perform a bariatric operation
  • No contraindications for the use of a rich carbohydrate drink

Exclusion Criteria:

  • No consent to participate in the study
  • Age under 18 years
  • The intolerance of the carbohydrate drink used in the test
  • The contraindications to perform bioimpedance measurements of body composition

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Carbohyrate loading
Group A will receive 400ml of the carbohydrate rich drink, Nutricia preOp 2 hours before operation. This is the intervention group.
A clear, non-carbonated lemon-flavored, iso-osmolar carbohydrate drink for preoperative surgical patients. Used in studies supporting the Enhanced Recovery After Surgery (ERAS) Society Consensus Guidelines.
No Intervention: Fasting
Group B will be prepared before the operation with a 24-hour fasting. This is the current clinical standard.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
QoR40 score
Time Frame: 1st postoperatie day
Quality of recovery after surgery will be assessed by the QoR40 survey Full scale title: Quality of Recovery 40-item questionnaires range from 40 (extremely poor. quality of recovery) to 200 (excellent quality of recovery)
1st postoperatie day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HOMA-IR
Time Frame: first assay one month before the operation, the second assay on the first postoperative day
changes in insulin resistance will be assessed with HOMA index (Homeostatic Model Assessment for Insulin Resistance)
first assay one month before the operation, the second assay on the first postoperative day
Body composition
Time Frame: first assay one month before the operation, the second assay on the first postoperative day
changes in body composition will be assessed by electric bioimpedance method
first assay one month before the operation, the second assay on the first postoperative day
Length of hospital stay
Time Frame: From the time of hospital admission following surgery, until the time of hospital discharge; assessed from day of hospital admision up to 30 days
length of stay record in hours
From the time of hospital admission following surgery, until the time of hospital discharge; assessed from day of hospital admision up to 30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maciej Wilczyński, General Surgery Resident, PhD Fellow, Teaching Assistant

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

July 20, 2020

Primary Completion (Anticipated)

July 20, 2021

Study Completion (Anticipated)

October 31, 2021

Study Registration Dates

First Submitted

July 12, 2020

First Submitted That Met QC Criteria

July 21, 2020

First Posted (Actual)

July 24, 2020

Study Record Updates

Last Update Posted (Actual)

July 24, 2020

Last Update Submitted That Met QC Criteria

July 21, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • PreOpxBariatric

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

Medical University of Gdańsk will be the owner of data

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity, Morbid

Clinical Trials on Nutricia PreOp

3
Subscribe